Yahoo Web Search

Search results

  1. Feb 28, 2017 · In 1904, he founded the Behringwerke (Behring Company) as a spinoff of his academic work. The company produced a number of sera and vaccines and rapidly expanded when WWI broke out and the demand for vaccines, notably against tetanus, sky-rocketed. Behring died on 31 March 1917.

  2. Dec 3, 2001 · Active Protective Vaccination against Diphtheria. Old vials (1897 and 1906) with hand-written labels. The therapeutic serum developed by Behring prevented diphtheria for only a short period of time. In 1901, Behring, therefore, for the first time, used a diphtheria innoculation of bacteria with reduced virulence.

  3. Apr 10, 2017 · Emil von Behring (1854–1917) discovered passive immunization as an effective treatment for diphtheria and tetanus.

    • Stefan H. E. Kaufmann
    • Kaufmann@mpiib-berlin.mpg.de
    • 2017
  4. The first vaccine for passive immunology was discovered by a group of German scientists under the leadership of Emil von Behring in 1890. The first inactive tetanus toxoid was discovered and produced in 1924.

  5. Feb 28, 2017 · A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed.

    • Stefan H. E. Kaufmann
    • 2017
  6. Apr 10, 2017 · Emil von Behring (1854–1917) discovered passive immu nization as an effective treatment for diphtheria and teta nus. Moreover, he brought this discovery from bench to bedside, and his serum...

  7. Dec 1, 2022 · Behring directed most of the firm’s activities, which centered on the production of tetanus serum and tuberculosis vaccines. Behringwerke became one of the first biomedical firms run by a scientist.

  1. People also search for